Annual Drug Patent Expirations for ADLARITY
Adlarity is a drug marketed by Corium and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug.
This drug has seventy-one patent family members in eleven countries.
The generic ingredient in ADLARITY is donepezil hydrochloride. One supplier is listed for this compound. Additional details are available on the donepezil hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
